Effects of benazepril hydrochloride in cats with experimentally induced or spontaneously occurring chronic renal failure

Journal of Veterinary Medical Science

Volumn 69, Issue 10, 2007, Pages 1015-1023

  Watanabe, Toshifumi ^a   Mishina, Mika ^a  

^a AZABU UNIVERSITY   (Japan)

Author keywords

Benazepril hydrochloride; Chronic renal failure; Feline; Hypertension

Indexed keywords

BENAZEPRIL; BENZAZEPINE DERIVATIVE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ANIMAL; ANIMAL DISEASE; ARTICLE; CAT; CAT DISEASE; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; DOSE RESPONSE; FEMALE; MALE;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BENZAZEPINES; CAT DISEASES; CATS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; KIDNEY FAILURE, CHRONIC; MALE;

FELIDAE;

EID: 36249016896     PISSN: 09167250     EISSN: 13477439     Source Type: Journal    
DOI: 10.1292/jvms.69.1015     Document Type: Article

References (44)

1. Anderson, L.J. and Fisher, E.W. 1968. The blood pressure in canine interstitial nephritis. Res. Vet. Sci. 9: 304-313.
2. Anderson, W.P., Ramsey, D.E. and Takata, M. 1990. Development of hypertension from unilateral renal artery stenosis in conscious dogs. Hypertension 16: 441-451.
3. Bell, D.R., Hollingsworth, S.F. and Overbeck, H.W. 1987. Decreased intraocular pressure in dogs with one-kidney, one wrapped hypertension. Hypertension 10: 152-156.
4. Bovee, K.C., Littman, M.P., Crabtree, B.J. and Aguirre, G. 1989. Essential hypertension in a dog. J. Am. Vet. Med. Assoc 195: 81-86.
5. Brenner, B.M., Cooper, M.E., de Zeeuw, D., Keane, W.F., Mitch, W.E., Parving, H.-H., Remuzzi, G., Snapinn, S.M., Zhang, Z., Shahinfar, S. and the RENAAL Study investigators. 2001. Effects of locartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. New Engl. J. Med. 345: 861-869.
6. Brenner, B.M., Meyer, T.W. and Hostetter, T.H. 1982. Dietary protein intake and progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease. New Engl. J. Med. 307: 652-659.
7. Brown, S.A., Brown, C.A., Jacobs, G., Stiles, J., Hendi, R.S. and Wilson, S. 2001. Effects of the angiotensin converting enzyme inhibitor benazepril in cats with induced renal insufficiency. Am. J. Vet. Res. 62: 375-383.
8. Brown, S.A., Finco, D.R., Brown, C.A., Crowell, W.A., Alva R., Ericsson, G.E. and Cooper, T. 2003. Evaluation of the effects of inhibition of angiotensin converting enzyme with enalapril in dogs with induced chronic renal insufficiency. Am. J. Vet. Res. 64: 321-327.
9. Brown, S.A., Finco, D.R., Crowell, W.A., Choat, D.C. and Navar, L.G. 1990. Single-nephron adaptations to partial renal ablation in the dog. Am. J. Physiol. 258: F495-F503.
10. Coulter, D.B. and Keith, J.C. Jr. 1984. Blood pressures obtained by indirect measurement in conscious dogs. J. Am. Vet. Med. Assoc. 184: 1375-1378.
11. Cowgill, L.D. and Kallet, A.J. 1986. Systemic hypertension. pp. 360-364. In: Current Veterinary Therapy, 9th ed. (Krik, R. ed.), WB Saunders, Pennsylvania.
12. Griffin, K.A., Picken, M. and Bidani, A.K. 1994. Method of renal mass reduction is a critical modulator of subsequent hypertension and glomerular injury. J. Am. Soc. Nephrol. 4: 2023-2031.
13. Guyton, A.C. 1992. Kidney and fluids in pressure regulation. Small volume but large pressure changes. Hypertension 19 (Suppl.): I2-I8.
14. Hou, F.F., Zhang, X., Zhang, G.H., Xie, D., Chen, P.Y., Zhang, W.R., Jiang, J.P., Liang, M., Wang, G.B., Liu, Z.R. and Geng, R.W. 2006. Efficacy and safety of benazepril for advanced chronic renal insufficiency. New Engl. J. Med. 354: 189-191.
15. Imanishi, M., Akabane, S., Takamiya, M., Kawamura, M., Matsushima, Y., Kuramochi, M. and Omae, T. 1992. Critical degree of renal arterial stenosis that causes hypertension in dogs. Angiology 10: 833-842.
16. Kim, S. and Iwao, H. 2000. Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases. Pharamacol. Rev. 52: 11-34.
17. King, J.N., Humbert-Droz, E. and Maurer, M. 1999. Plasma angiotensin converting enzyme activity and pharmacokinetics of benazepril and benazeprilat in cats after single and repeated oral administration of benazepril.HCl. J. Vet. Pharmacol. Ther. 22: 360-367.
18. King, J.N., Strehlau, G., Wernsing, J. and Brown, S.A. 2002. Effect of renal insufficiency on the pharmacokinetics and pharmacodynamics of benazepril in cats. J. Vet. Pharmacol. Ther. 25: 371-378.
19. Kitagawa, H., Eguchi, T., Kitoh, K., Ohba, Y., Kondo, M., Nakano, M. and Sasaki, Y. 2000. Plasma concentrations of an angiotensin-converting enzyme inhibitor, benazepril, and its active metabolite, benazeprilat, after repeated administrations of benazepril in dogs with experimental kidney impairment. J. Vet. Med. Sci. 62: 179-185.
20. Kobayashi, D.L., Peterson, M.E., Graves T.K., Lesser, M. and Nichols, C.E. 1990. Hypertension in cats with chronic renal failure or hyperthyroidism. J. Vet. Intern. Med. 4: 58-62.
21. Koushanpour, E. and Behnia, R. 1987. Partition of carotid baroreceptor response in two-kidney hypertensive dogs. Am. J. Physiol. 253: R568-R575.
22. Laragh, J.H. and Pickering, T.G. 1991. Essential Hypertension. pp. 1909-1936. In: The Kidney. (Brenner, B.M. and Rector, F.C. eds.), WB Saunders, Philadelphia.
23. Lefebvre, H.P. and Toutain, P.L. 2004. Angiotensin-converting enzyme inhibitors in the therapy of renal diseases. J. Vet. Pharmacol. Ther. 27: 265-281.
24. Liard, J.F. 1981. Regional blood flows in salt loading hypertension in the dog. Am. J. Physiol. 240: H361-H367.
25. Littman, M.P. 1994. Spontaneous systemic hypertension in 24 cats. J. Vet. Intern. Med. 8: 79-86.
26. Littman, M.P., Robertson, J.L. and Bovee, K.C. 1988. Spontaneous systemic hypertension in dogs: Five cases (1981-1983). J. Am. Vet. Med. Assoc. 193: 486-494.
27. Maschio, G., Alberti, D., Janin, G., Locatelli, F., Mann, J.F.E., Motolese, M., Ponticelli, C., Ritz, E. and Zucchelli, P. 1996. Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. New Engl. J. Med. 334: 939-945.
28. Mishina, M., Watanabe, N. and Watanabe, T. 2006. Diurnal variations of blood pressure in cats. J. Vet. Med. Sci. 68: 243-248.
29. Mishina, M., Watanabe, T., Fujii, K., Maeda, H., Wakao, Y. and Takahashi, M. 1998. Non-invasive blood pressure measurements in cats: clinical significance of hypertension associated with chronic renal failure. J. Vet. Med. Sci. 60: 805-808.
30. Miyazaki, M., Okunishi, H., Okamura, T. and Toda, N. 1987. Elevated vascular angiotensin converting enzyme in chronic two-kidney, one clip hypertension in the dog. J. Hypertens. 5: 155-160.
31. Papanek, P.E., Bovee, K.C., Skelton, M.M. and Cowley, A.W., Jr. 1993. Chronic pressure-natriuresis relationship in dogs with inherited essential hypertension. Am. J. Hypertens. 6: 960-967.
32. Pinto, J.M., Kirby, D.A. and Lown, B. 1991. Decrease in repetitive extrasystole threshold during epinephrine infusion is enhanced in conscious dogs with perinephritic hypertension. Physiol. Behav. 49: 383-386.
33. Remuzzi, G., Benigni, A. and Remuzzi, A. 2006. Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes. J. Clin. Invest. 116: 288-296.
34. Remuzzi, A., Gagliardini, E., Sangalli, F., Bonomelli, M., Piccinelli, M., Benigni, A. and Remuzzi, G. 2006. ACE inhibition reduces glomerulosclerosis and regenerates glomerular tissue in a model of progressive renal disease. Kidney Int. 69: 1124-1130.
35. Remuzzi, G., Ruggenenti, P. and Perico, N. 2002. Chronic renal diseases: Renoprotective benefits of renin-angiotensin system inhibition. Ann. Intern. Med. 136: 604-615.
36. Robertson, J.L., Goldschmidt, M., Kronfeld, D.S., Tomaszewski, J.E., Hill, G.S. and Bovee, K.C. 1986. Long-term renal responses to high dietary protein in dogs with 75% nephrectomy. Kidney Int. 29: 511-519.
37. Rosenfeld, J.B. and Zabludowski, J. 1989. The renin-angiotensin system, the kidney, and hypertension. J. Cardiovasc. Pharmacol. 13 (Suppl. 3): S22-S26.
38. Ross, L.A. 1992. Hypertension and chronic renal failure. Sem. Vet. Med. Surg. (Small Anim.) 7: 221-226.
39. Spangler, W.L., Gribble, D.H. and Weiser, M.G. 1977. Canine hypertension: A review. J. Am. Vet. Med. Assoc. 170: 995-998.
40. Stiles, J., Polzin, D.J. and Bistner, S. 1994. The prevalence of retiopathy in cats with systemic hypertension and chronic renal failure or hyperthyroidism. J. Am. Anim. Hosp. Assoc. 30: 564-572.
41. Tippett, F.E., Padgett, G.A., Eyster, G., Blanchard, G. and Bell, T. 1987. Primary hypertension in a colony of dogs. Hypertension 9: 49-58.
42. Toutain, P.L., Lefebvre, H.P. and Laroute, V. 2002. New insights on effect of kidney insufficiency on disposition of angiotensin-converting enzyme inhibitors: case of enalapril and benazepril in dogs. J. Vet. Pharmacol. Ther. 292: 1094-1103.
43. Yu, H.T. 2003. Progression of chronic renal failure. Arch. Intern. Med. 163: 1417-1429.
44. 14C]- benazepril hydrochloride in rat, dog and baboon. Absorption, distribution, kinetics, biotransformation and excretion. Arzneimittelforschung 39: 62-67.